首页> Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology> Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review?

Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review?

导出原文传递

翻译打印收藏纠错

第一作者： Michal Miroslaw,Farkowski

作者： Michal Miroslaw,Farkowski ^[1] ; Michal,Karlinski ^[2] ; Mariusz,Pytkowski ^[3] ; Carlo,de Asmundis ^[4] ; Michal,Lewandowski ^[5] ; Giacomo,Mugnai ^[6] ; Giulio,Conte ^[7] ; Eloi,Marijon ^[8] ; Ante,Anic ; Serge,Boveda ; Rui,Providencia

作者单位： Département de Cardiologie, Université Paris-Descartes, H?pital Européen Georges Pompidou ^[1] Department of Cardiology, University Clinical Hospital Split ^[2] Heart Rhythm Management Centre, Universitair Ziekenhuis Brussel—Vrije Universiteit Brussel ^[3] St Bartholomew’s Hospital, Barts Heart Centre, Barts Health NHS Trust ^[4] II Department of Heart Arrhythmia, National Institute of Cardiology ^[5] II Department of Neurology, Institute of Psychiatry and Neurology ^[6] Division of Cardiology, West Vicenza General Hospitals ^[7] Cardiology Department, Cardiocentro Ticino Institute ^[8]

关键词 Mexiletine Structural heart disease Implantable cardioverter defibrillator Shock Arrhythmia Ventricular tachycardia Systematic review

发布时间 2023-02-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交